Matches in Wikidata for { <http://www.wikidata.org/entity/Q49901672> ?p ?o ?g. }
- Q49901672 description "2018 nî lūn-bûn" @default.
- Q49901672 description "2018年の論文" @default.
- Q49901672 description "2018年学术文章" @default.
- Q49901672 description "2018年学术文章" @default.
- Q49901672 description "2018年学术文章" @default.
- Q49901672 description "2018年学术文章" @default.
- Q49901672 description "2018年学术文章" @default.
- Q49901672 description "2018年学术文章" @default.
- Q49901672 description "2018年學術文章" @default.
- Q49901672 description "2018年學術文章" @default.
- Q49901672 description "2018年學術文章" @default.
- Q49901672 description "2018年學術文章" @default.
- Q49901672 description "2018年學術文章" @default.
- Q49901672 description "2018년 논문" @default.
- Q49901672 description "article científic" @default.
- Q49901672 description "article scientific" @default.
- Q49901672 description "article scientifique" @default.
- Q49901672 description "articol științific" @default.
- Q49901672 description "articolo scientifico" @default.
- Q49901672 description "artigo científico" @default.
- Q49901672 description "artigo científico" @default.
- Q49901672 description "artigo científico" @default.
- Q49901672 description "artikel ilmiah" @default.
- Q49901672 description "artikull shkencor" @default.
- Q49901672 description "artikulong pang-agham" @default.
- Q49901672 description "artykuł naukowy" @default.
- Q49901672 description "artículo científico publicado en 2018" @default.
- Q49901672 description "artículu científicu" @default.
- Q49901672 description "bilimsel makale" @default.
- Q49901672 description "bài báo khoa học" @default.
- Q49901672 description "naučni članak" @default.
- Q49901672 description "scienca artikolo" @default.
- Q49901672 description "scientific article published on 15 January 2018" @default.
- Q49901672 description "scientific article published on 15 January 2018" @default.
- Q49901672 description "scientific article published on 15 January 2018" @default.
- Q49901672 description "teaduslik artikkel" @default.
- Q49901672 description "tieteellinen artikkeli" @default.
- Q49901672 description "tudományos cikk" @default.
- Q49901672 description "vedecký článok" @default.
- Q49901672 description "vetenskaplig artikel" @default.
- Q49901672 description "videnskabelig artikel" @default.
- Q49901672 description "vitenskapelig artikkel" @default.
- Q49901672 description "vitskapeleg artikkel" @default.
- Q49901672 description "vědecký článek" @default.
- Q49901672 description "wetenschappelijk artikel" @default.
- Q49901672 description "wissenschaftlicher Artikel" @default.
- Q49901672 description "επιστημονικό άρθρο" @default.
- Q49901672 description "мақолаи илмӣ" @default.
- Q49901672 description "наукова стаття, опублікована в січні 2018" @default.
- Q49901672 description "научна статия" @default.
- Q49901672 description "научная статья" @default.
- Q49901672 description "научни чланак" @default.
- Q49901672 description "научни чланак" @default.
- Q49901672 description "מאמר מדעי" @default.
- Q49901672 description "مقالة علمية نشرت في 15 يناير 2018" @default.
- Q49901672 description "১৫ জানুয়ারি ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q49901672 description "บทความทางวิทยาศาสตร์" @default.
- Q49901672 description "სამეცნიერო სტატია" @default.
- Q49901672 name "Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)." @default.
- Q49901672 name "Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)." @default.
- Q49901672 type Item @default.
- Q49901672 label "Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)." @default.
- Q49901672 label "Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)." @default.
- Q49901672 prefLabel "Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)." @default.
- Q49901672 prefLabel "Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)." @default.
- Q49901672 P1433 Q49901672-60E3E8E9-88ED-48D8-8EA4-1A9CBD425C47 @default.
- Q49901672 P1476 Q49901672-1D069A1F-44DD-46E9-AC99-78497D51878E @default.
- Q49901672 P2093 Q49901672-0085CF60-3C85-4F3B-81B3-E2B47B898AD0 @default.
- Q49901672 P2093 Q49901672-00E01F3C-070D-4078-AF75-4B704263ADD8 @default.
- Q49901672 P2093 Q49901672-0A2AEF85-AE14-4EDF-8CE1-195FCDC4F84D @default.
- Q49901672 P2093 Q49901672-291544E0-6275-491C-99F1-D7209D02FFBA @default.
- Q49901672 P2093 Q49901672-44924FF8-B922-4DBA-93F9-1D5E1CFA8F4D @default.
- Q49901672 P2093 Q49901672-7571DF3B-5830-486D-A235-C17D22C8B3B2 @default.
- Q49901672 P2093 Q49901672-8429DB10-7856-4240-A581-892BBA3953C1 @default.
- Q49901672 P2093 Q49901672-A84667DB-6980-4FAE-BBB1-C7DB6CFE25D1 @default.
- Q49901672 P2093 Q49901672-BB5711FB-ED18-487E-9504-E54CAAE968A4 @default.
- Q49901672 P2093 Q49901672-C8E80D64-10B3-4B9C-9D7D-8FB88605C4E6 @default.
- Q49901672 P2093 Q49901672-D79E53F3-3F28-44D2-A050-A38838DE641D @default.
- Q49901672 P2093 Q49901672-EFF37125-9397-4602-B51F-82BBF128F007 @default.
- Q49901672 P2093 Q49901672-F97F9E73-39ED-4FA4-A2B0-65EA67407B29 @default.
- Q49901672 P2093 Q49901672-FDC87EB5-4D85-47EB-8284-9D9F9453ECB3 @default.
- Q49901672 P31 Q49901672-BC6B1679-B958-4375-87A5-5079CA06B049 @default.
- Q49901672 P356 Q49901672-BB361207-FFB6-4107-A344-28E33042D88E @default.
- Q49901672 P407 Q49901672-5C816F98-2C9C-4BB9-A500-783C9629DE98 @default.
- Q49901672 P577 Q49901672-16423430-9281-4436-BCAE-EB822C987EE5 @default.
- Q49901672 P698 Q49901672-80330EF6-CFDC-4E1D-A55D-CEFBDC92A68F @default.
- Q49901672 P921 Q49901672-60967AE1-B145-4980-99CF-19A900D8DF62 @default.
- Q49901672 P921 Q49901672-B407ADCA-8EC9-4F1F-B03B-3074C67472A9 @default.
- Q49901672 P921 Q49901672-CF3708A0-1447-41C4-9758-71DD65D54AFF @default.
- Q49901672 P356 J.JAAD.2018.01.017 @default.
- Q49901672 P698 29353026 @default.
- Q49901672 P1433 Q15757046 @default.
- Q49901672 P1476 "Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)." @default.
- Q49901672 P2093 "Alain Taïeb" @default.
- Q49901672 P2093 "Athina Voulgari" @default.
- Q49901672 P2093 "Carsten Flohr" @default.
- Q49901672 P2093 "Chin-Yu Lin" @default.
- Q49901672 P2093 "Eric L Simpson" @default.
- Q49901672 P2093 "Howard Sofen" @default.
- Q49901672 P2093 "Karl Yen" @default.